500 patients67,039 observations150 daysLIVE

Patient P-03405

Synthetic patientONX-7 · Day 105 · 75+ · M · baseline S16Open companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
62%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 ONX-7 startedBaseline state S16

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • GI instability+19
  • Toxicity+19
  • Inflammatory activity+18
  • Nutritional resilience-14
  • Treatment adherence-12

What helped?

No interventions yet.

    LIFE OS recommendation
    GI Support Protocol GI-04
    62%
    probability of meaningful tolerance improvement
    • 284 similar trajectories
    • 81% showed improvement
    • median effect visible after 8 days

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Mucosal barrier integrity 80
      • DNAFUT2 non-secretor lowers mucosal fucosylation
      • MicrobiomeAkkermansia low → thinner mucus layer
      • Daily logGI symptom score 53 and rising
    • Inflammatory signalling 70
      • DNAIL6 -174 variant raises baseline inflammatory tone
      • MicrobiomeBacteroides fragilis expansion
      • BloodInflammatory load index 50
    • Butyrate / short-chain fatty acid production 55
      • MicrobiomeButyrate capacity 28/100
      • Daily logFibre intake low in recent food logs
    • Autonomic recovery 25
      • WearableResting HR 74 bpm
    DNA
    Fictional pharmacogenomic panel
    • FUT2 rs601338 AA (non-secretor)
      Reduced mucosal fucosylation
    • IL6 -174 G/C
      Higher inflammatory tone
    • CYP2D6 Normal metabolizer
      Expected exposure
    Microbiome
    Shannon diversity 2.2 · butyrate capacity 28/100
    • Akkermansia muciniphilaLow
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisHigh
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeNormal
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    54 ms
    Sleep
    7.4 h
    Steps
    6,555
    Resting HR
    68 bpm
    Daily log: GI score 53, nutritional resilience 45, adherence 88.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Prepare a plain, low-fat pasta or rice meal and note how it feels afterwards
    • Choose a freshly cooked, lean protein; avoid frying, rich sauces and leftovers for now
    • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Track each bowel movement today: time, stool form, urgency, overnight waking
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • Electrolyte solution, one sachet after any loose stool
    • Fictional demo item: oral nutrition supplement with lunch

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0322145%S06GI-04no change64
    P-0334644%S17GI-04improved71
    P-0312043%S1461
    P-0316043%S1863
    P-0329242%S1462
    P-0337840%S1059
    P-0320739%S0461
    P-0302738%S2062
    P-0307438%S0160
    P-0324537%S0257
    P-0328737%S1755
    P-0337937%S12GI-04improved51